Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 254

1.

Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE.

Moses KA, Paciorek AT, Penson DF, Carroll PR, Master VA.

J Clin Oncol. 2010 Feb 20;28(6):1069-74. doi: 10.1200/JCO.2009.26.2469. Epub 2010 Jan 25.

2.

Prognostic significance of race on biochemical control in patients with localized prostate cancer treated with permanent brachytherapy: multivariate and matched-pair analyses.

Lee LN, Barnswell C, Torre T, Fearn P, Kattan M, Potters L.

Int J Radiat Oncol Biol Phys. 2002 Jun 1;53(2):282-9.

PMID:
12023131
3.

Impact of patient educational level on treatment for patients with prostate cancer: data from CaPSURE.

Kane CJ, Lubeck DP, Knight SJ, Spitalny M, Downs TM, Grossfeld GD, Pasta DJ, Mehta SS, Carroll PR.

Urology. 2003 Dec;62(6):1035-9.

PMID:
14665350
4.

Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation.

Demanes DJ, Brandt D, Schour L, Hill DR.

Am J Clin Oncol. 2009 Aug;32(4):342-7. doi: 10.1097/COC.0b013e31818cd277.

PMID:
19398902
5.

Patterns of primary and secondary therapy for prostate cancer in elderly men: analysis of data from CaPSURE.

Konety BR, Cowan JE, Carroll PR; CaPSURE Investigators.

J Urol. 2008 May;179(5):1797-803; discussion 1803. doi: 10.1016/j.juro.2008.01.044. Epub 2008 Mar 17.

PMID:
18343440
6.
7.

Role of family history and ethnicity on the mode and age of prostate cancer presentation.

Cotter MP, Gern RW, Ho GY, Chang RY, Burk RD.

Prostate. 2002 Mar 1;50(4):216-21.

PMID:
11870799
8.

Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.

Albain KS, Unger JM, Crowley JJ, Coltman CA Jr, Hershman DL.

J Natl Cancer Inst. 2009 Jul 15;101(14):984-92. doi: 10.1093/jnci/djp175. Epub 2009 Jul 7.

9.

The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry.

Cooperberg MR, Broering JM, Litwin MS, Lubeck DP, Mehta SS, Henning JM, Carroll PR; CaPSURE Investigators.

J Urol. 2004 Apr;171(4):1393-401. Review.

10.

Incidence of urethral stricture after primary treatment for prostate cancer: data From CaPSURE.

Elliott SP, Meng MV, Elkin EP, McAninch JW, Duchane J, Carroll PR; CaPSURE Investigators.

J Urol. 2007 Aug;178(2):529-34; discussion 534. Epub 2007 Jun 13.

PMID:
17570425
11.

Rates of biochemical remission remain higher in black men compared to white men after radical prostatectomy despite similar trends in prostate specific antigen induced stage migration.

Wood HM, Reuther AM, Gilligan TD, Kupelian PA, Modlin CS Jr, Klein EA.

J Urol. 2007 Oct;178(4 Pt 1):1271-6. Epub 2007 Aug 14.

PMID:
17698101
12.

Prostate cancer stage shift has eliminated the gap in disease-free survival in black and white American men after radical prostatectomy.

Bianco FJ Jr, Wood DP Jr, Grignon DJ, Sakr WA, Pontes JE, Powell IJ.

J Urol. 2002 Aug;168(2):479-82.

PMID:
12131292
13.

Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes.

Agarwal PK, Sadetsky N, Konety BR, Resnick MI, Carroll PR; Cancer of the Prostate Strategic Urological Research Endeavor (CaPSURE).

Cancer. 2008 Jan 15;112(2):307-14.

14.

Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer.

Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL.

Ann Intern Med. 2008 Mar 18;148(6):435-48. Epub 2008 Feb 4. Review. Erratum in: Ann Intern Med. 2008 Jun 3;148(11):888.

PMID:
18252677
15.

Does race affect postoperative outcomes in patients with low-risk prostate cancer who undergo radical prostatectomy?

Resnick MJ, Canter DJ, Guzzo TJ, Brucker BM, Bergey M, Sonnad SS, Wein AJ, Malkowicz SB.

Urology. 2009 Mar;73(3):620-3. doi: 10.1016/j.urology.2008.09.035. Epub 2008 Dec 18.

PMID:
19100607
16.
17.

Hospice usage by minorities in the last year of life: results from the National Mortality Followback Survey.

Greiner KA, Perera S, Ahluwalia JS.

J Am Geriatr Soc. 2003 Jul;51(7):970-8.

PMID:
12834517
18.

Clinical characteristics of African-American men with hereditary prostate cancer: the AAHPC Study.

Ahaghotu C, Baffoe-Bonnie A, Kittles R, Pettaway C, Powell I, Royal C, Wang H, Vijayakumar S, Bennett J, Hoke G, Mason T, Bailey-Wilson J, Boykin W, Berg K, Carpten J, Weinrich S, Trent J, Dunston G, Collins F.

Prostate Cancer Prostatic Dis. 2004;7(2):165-9.

PMID:
15175665
19.
20.

Uncertainty in prostate cancer. Ethnic and family patterns.

Germino BB, Mishel MH, Belyea M, Harris L, Ware A, Mohler J.

Cancer Pract. 1998 Mar-Apr;6(2):107-13. Erratum in: Cancer Pract 1998 Jul-Aug;6(4):205.

PMID:
9573910

Supplemental Content

Support Center